{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:43:06Z","timestamp":1794559386405,"version":"4.9.1"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:italic>Neisseria meningitidis<\/jats:italic>\n            represents a pathogen of great public health importance in both developed and developing countries. Resistance to some antimicrobial agents used either for therapy of invasive infections or for prophylaxis of case contacts has long been recognized, although specific guidelines for susceptibility testing have not been fully developed. We have examined the susceptibilities of a collection of 442 meningococcal clinical isolates from 15 countries to 16 antimicrobial agents. These included isolates recovered between 1917 and 2004, with representatives of all major serogroups. All isolates were tested by the Clinical and Laboratory Standards Institute (formerly NCCLS) broth microdilution method using Mueller-Hinton lysed horse blood broth, while a subset of 102 isolates was tested by agar dilution using Mueller-Hinton sheep blood agar. Most isolates provided adequate growth for MIC determinations by both broth and agar methods. Growth in broth was enhanced by CO\n            <jats:sub>2<\/jats:sub>\n            incubation and was required for two strains (1.7%). MICs of the study drugs compared favorably between the broth and agar methods (79 to 100% essential agreement), and MICs also generally agreed closely (92 to 100% essential agreement, excluding azithromycin) between broth tests incubated in the two different atmospheres. Elevated penicillin and ampicillin MICs (\u22650.12 \u03bcg\/ml and \u22650.25 \u03bcg\/ml, respectively) occurred in 14.3% and 8.6% of strains and were associated with polymorphisms of the\n            <jats:italic>penA<\/jats:italic>\n            gene encoding a modified penicillin-binding protein 2. None of the 442 isolates produced beta-lactamase. Elevated tetracycline and doxycycline (but not minocycline) MICs were associated with efflux-mediated resistance encoded by\n            <jats:italic>tet<\/jats:italic>\n            (B) in 13 strains. Resistance to sulfisoxazole in 21.7% of strains and to trimethoprim-sulfamethoxazole in 21.0% resulted from polymorphisms of\n            <jats:italic>folP<\/jats:italic>\n            encoding a modified dihydropteroate synthetase. Seven strains were resistant to rifampin due to mutations in the\n            <jats:italic>rpoB<\/jats:italic>\n            gene, and two strains were resistant to chloramphenicol due to production of chloramphenicol acetyltransferase mediated by\n            <jats:italic>catP<\/jats:italic>\n            . Two strains had reduced quinolone susceptibility due to mutations of\n            <jats:italic>gyrA<\/jats:italic>\n            . The determination of the susceptibilities of a large group of meningococcal strains (including strains with characterized resistance mechanisms) to 16 antimicrobial agents has served as the essential first step in defining susceptibility testing breakpoints specific for this organism.\n          <\/jats:p>","DOI":"10.1128\/jcm.43.7.3162-3171.2005","type":"journal-article","created":{"date-parts":[[2005,7,6]],"date-time":"2005-07-06T23:18:52Z","timestamp":1120691932000},"page":"3162-3171","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":74,"title":["Susceptibility of\n            <i>Neisseria meningitidis<\/i>\n            to 16 Antimicrobial Agents and Characterization of Resistance Mechanisms Affecting Some Agents"],"prefix":"10.1128","volume":"43","author":[{"given":"James H.","family":"Jorgensen","sequence":"first","affiliation":[{"name":"Department of Pathology, The University of Texas Health Science Center, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Crawford","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Health Science Center, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin R.","family":"Fiebelkorn","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Texas Health Science Center, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3625-3628.2001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.3.285"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1705-1707.2000"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3336-3338.2003"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh045"},{"key":"e_1_3_2_7_2","first-page":"54","year":"1988","unstructured":"Botha, P. 1988. Penicillin-resistant Neisseria meningitidis in southern Africa. Lanceti:54.","journal-title":"Lancet"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01992178"},{"key":"e_1_3_2_9_2","first-page":"11","volume":"49","year":"2000","unstructured":"Centers for Disease Control and Prevention. 2000. Meningococcal disease and college students. Morb. Mortal. Wkly. Rep.49:11-12.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_10_2","first-page":"97","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Risk of meningococcal disease associated with the Hajj of 2001. Morb. Mortal. Wkly. Rep.50:97-99.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_11_2","first-page":"141","volume":"51","year":"2002","unstructured":"Centers for Disease Control and Prevention. 2002. Laboratory-acquired meningococcal disease\u2014United States, 2000. Morb. Mortal. Wkly. Rep.51:141-144.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_12_2","unstructured":"Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Supplement M100-S15. Clinical and Laboratory Standards Institute Wayne Pa."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/517450"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/516284"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1198-1200.2005"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1941.02820240026008"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.18.020167.002431"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.2.424"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.536-540.2005"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01964130"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809243391302"},{"key":"e_1_3_2_22_2","first-page":"160","volume":"36","year":"2004","unstructured":"Hansman, D., S. Wati, A. Lawrence, and J. Turnidge. 2004. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999. Pathology36:160-165.","journal-title":"Pathology"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1943.02840410017006"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2000.tb00360.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.8.1728"},{"key":"e_1_3_2_26_2","first-page":"139","volume":"186","year":"1963","unstructured":"Millar, J. W., E. E. Siess, H. A. Feldman, C. Silverman, and P. Frank. 1963. In vivo and in vitro resistance to sulfadizine in strains of Neisseria meningitidis. JAMA186:139-141.","journal-title":"JAMA"},{"key":"e_1_3_2_27_2","unstructured":"NCCLS. 2001. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline M23-A2. NCCLS Wayne Pa."},{"key":"e_1_3_2_28_2","unstructured":"NCCLS. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. NCCLS Wayne Pa."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.6.747"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.1.98"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(01)00289-9"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/313599"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.394"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg452"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.2.219"},{"key":"e_1_3_2_37_2","first-page":"359","volume":"33","year":"2001","unstructured":"Tapsall, J. W., T. Shultz, E. Limnios, R. Munro, J. Mercer, R. Porritt, J. Griffith, G. Hogg, G. Lum, A. Lawrence, D. Hansman, P. Collignon, P. Southwell, K. Ott, M. Gardam, C. J. L. Richardson, J. Bates, D. Murphy, and H. Smith. 2001. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999. Pathology33:359-361.","journal-title":"Pathology"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.1.144"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.2.453"},{"key":"e_1_3_2_40_2","first-page":"1152","volume":"341","year":"1993","unstructured":"Yagupsky, P., S. Ashkenazi, and C. Block. 1993. Rifampicin-resistant meningococci causing invasive disease and failure of chemoprophylaxis. Lancet341:1152-1153.","journal-title":"Lancet"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.7.3162-3171.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.7.3162-3171.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:34:13Z","timestamp":1646454853000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.7.3162-3171.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1128\/JCM.43.7.3162-3171.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.7.3162-3171.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"2004-12-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-03-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}